FEATURED/ARCHIVES (04/05/24)
Estimation of Subjective Quality of Life in Schizophrenic Patients Using Speech Features · March 2023
Articles
Frontiers in Rehabilitation Sciences
Searching for Biomarkers in Schizophrenia and Psychosis: Case-Control Study Using Capillary Electrophoresis and Liquid Chromatography Time-of-Flight Mass Spectrometry and Systematic Review for Biofluid Metabolites · December 2021
Articles
Neuropsychopharmacology Reports
Facilitative Effects of Transcranial Direct Current Stimulation on Semantic Memory Examined by Text-Mining Analysis in Patients with Schizophrenia · February 2021
Articles
Frontiers in Neurology
Efficacy of a Gluten-Restricted Diet in Treatment-Resistant Schizophrenia Patients with Immunological Gluten Sensitivity: A Case Report · January 2022
Abstracts
Schizophrenia Research
Homocysteine Level, Body Mass Index and Clinical Correlates in Chinese Han Patients with Schizophrenia · September 2020
Articles
Scientific Reports
Risk Factors for Readmission in Schizophrenia Treated with Combined Psychoeducation and Standard Therapy · January 2022
Articles
Neuropsychopharmacology Reports
Comparison between Olanzapine and Aripiprazole Treatment for 104 Weeks After Hospital Discharge in Schizophrenia Spectrum Disorders: A Multicenter Retrospective Cohort Study in a Real-World Setting · July 2023
Abstracts
Psychopharmacology
Prospective Five-Year Follow-Up of Patients with Schizophrenia Suspected with Parkinson’s Disease · May 2022
Articles
Parkinson’s Disease
Clozapine Once-Daily versus Divided Dosing Regimen: A Cross-Sectional Study in Japan · March 2022
Abstracts
Journal of Clinical Psychopharmacology
Aripiprazole vs. Brexpiprazole for Acute Schizophrenia: A Systematic Review and Network Meta-Analysis · January 2020
Abstracts
Psychopharmacology
Acceptance of the Deltoid Muscle Injection of Aripiprazole Long-Acting Injectable in the Patients with Schizophrenia · February 2020
Articles
Clinical Psychopharmacology and Neuroscience
What Is the Minimum Clinically Important Change in Negative Symptoms of Schizophrenia? PANSS Based Post-Hoc Analyses of a Phase III Clinical Trial · April 2022
Articles
Frontiers in Psychiatry
Neuroanatomical Heterogeneity and Homogeneity in Individuals at Clinical High Risk for Psychosis · July 2022
Articles
Translational Psychiatry
Pharmacological Treatment Algorithms for the Acute Phase, Agitation, and Maintenance Phase of First-Episode Schizophrenia: Japanese Society of Clinical Neuropsychopharmacology Treatment Algorithms · July 2021
Articles
Human Psychopharmacology: Clinical and Experimental
Association between the Examination Rate of Treatment-Resistant Schizophrenia and the Clozapine Prescription Rate in a Nationwide Dissemination and Implementation Study · December 2021
Articles
Neuropsychopharmacology Reports
Association of Structural Magnetic Resonance Imaging Measures with Psychosis Onset in Individuals at Clinical High Risk for Developing Psychosis: An ENIGMA Working Group Mega-Analysis · May 2021
Articles
JAMA Psychiatry
Case Report: Impact of Hyperthyroidism on Psychotic Symptoms in Schizophrenia Comorbid with Graves’ Disease · July 2023
Articles
Frontiers in Psychiatry
Relationship between Clozapine Exposure and the Onset of Appendicitis in Schizophrenia Patients: A Retrospective Cohort Study · October 2022
Articles
BMC Psychiatry
Long-Term Treatment with Long-Acting Injectable Antipsychotic in Schizophrenia Patients with and without Dopamine Supersensitivity Psychosis: A 6-Year Retrospective Comparative Study · July 2022
Abstracts
Journal of Clinical Psychopharmacology